All Stories

  1. Body Mass Index and Colorectal Cancer

    Article • February 2019, IntechOpen

    Prof Dr Faruk Nuri Aykan

  2. Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study

    Article • Surgical Oncology, September 2018, Elsevier

    Prof Dr Faruk Nuri Aykan

  3. Neoadjuvant volumetric modulated arc therapy in rectal cancer and the correlation of pathological response with diffusion-weighted MRI and apoptotic markers

    Article • Tumori Journal, May 2018, SAGE Publications

    Prof Dr Faruk Nuri Aykan

  4. Bevacuzimab May Be Less Effective in Obese Metastatic Colorectal Cancer Patients

    Article • Journal of Gastrointestinal Cancer, January 2018, Springer Science + Business Media

    Prof Dr Faruk Nuri Aykan

  5. Imatinib response of gastrointestinal stromal tumor patients with germline mutation on KIT exon 13: A family report

    Article • World Journal of Radiology, September 2017, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Prof Dr Faruk Nuri Aykan

  6. Evaluation of epidermal growth factor receptor serum levels and their association with clinicopathological characteristics in patients with colorectal cancer

    Article • Molecular and Clinical Oncology, September 2017, Spandidos Publications

    Prof Dr Faruk Nuri Aykan

  7. Benefit of Bevacizumab-Based Frontline Therapy in Patients with Metastatic Colorectal Cancer (mCRC): a Turkish Oncology Group Study

    Article • Journal of Gastrointestinal Cancer, April 2016, Springer Science + Business Media

    Prof Dr Faruk Nuri Aykan

  8. Red meat and colorectal cancer

    Article • Oncology Reviews, December 2015, PAGEPress Publications

    Prof Dr Faruk Nuri Aykan

  9. Clinical significance of serum claudin-1 and claudin-7 levels in patients with colorectal cancer

    Article • Molecular and Clinical Oncology, August 2015, Spandidos Publications

    Prof Dr Faruk Nuri Aykan

  10. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer

    Article • Biomedicine & Pharmacotherapy, July 2015, Elsevier

    Prof Dr Faruk Nuri Aykan

  11. Red meat subtypes and colorectal cancer risk

    Article • International Journal of Cancer, June 2015, Wiley

    Prof Dr Faruk Nuri Aykan

  12. Do serum nectin-2 levels have a prognostic effect in patients with colorectal cancer?

    Article • Journal of Clinical Oncology, May 2015, American Society of Clinical Oncology (ASCO)

    Prof Dr Faruk Nuri Aykan

  13. Clinical significance of serum claudin-7 levels in patients with colorectal cancer.

    Article • Journal of Clinical Oncology, May 2015, American Society of Clinical Oncology (ASCO)

    Prof Dr Faruk Nuri Aykan

  14. Prognostic roles of serum NEDD9 levels in patients with gastric cancer.

    Article • Journal of Clinical Oncology, May 2015, American Society of Clinical Oncology (ASCO)

    Prof Dr Faruk Nuri Aykan

  15. Epidemiology of colorectal cancer in Turkey: A cross-sectional disease registry study (A Turkish Oncology Group trial)

    Article • The Turkish Journal of Gastroenterology, March 2015, AVES Publishing Co.

    Prof Dr Faruk Nuri Aykan

  16. Clinical significance of serum vascular cell adhesion molecule-1(VCAM-1) in colorectal cancer.

    Article • Journal of Clinical Oncology, January 2015, American Society of Clinical Oncology (ASCO)

    Prof Dr Faruk Nuri Aykan

  17. Can Complementary 68Ga-DOTATATE and 18F-FDG PET/CT Establish the Missing Link Between Histopathology and Therapeutic Approach in Gastroenteropancreatic Neuroendocrine Tumors?

    Article • Journal of Nuclear Medicine, October 2014, Society of Nuclear Medicine

    Prof Dr Faruk Nuri Aykan

  18. The diagnostic, predictive, and prognostic role of serum cellular adhesion molecules (VCAM-1, EpCAM) levels in breast cancer patients.

    Article • Journal of Clinical Oncology, May 2014, American Society of Clinical Oncology (ASCO)

    Prof Dr Faruk Nuri Aykan

  19. Clinical significance of serum protein and mRNA level of insulin-like growth factor-1 (IGF-1) in patients with hepatocellular carcinoma.

    Article • Journal of Clinical Oncology, January 2014, American Society of Clinical Oncology (ASCO)

    Prof Dr Faruk Nuri Aykan

  20. Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy

    Article • Medical Oncology, August 2013, Springer Science + Business Media

    Prof Dr Faruk Nuri Aykan

  21. Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC)

    Article • Clinical & Translational Oncology, October 2012, Springer Science + Business Media

    Prof Dr Faruk Nuri Aykan

  22. Intercellular Communication

    Article • April 2012, IntechOpen

    Prof Dr Faruk Nuri Aykan

  23. The role of UFT in advanced gastric cancer

    Article • Annals of Oncology, January 2008, Oxford University Press (OUP)

    Prof Dr Faruk Nuri Aykan

  24. Message-adjusted network (MAN) hypothesis in gastro-entero-pancreatic (GEP) endocrine system

    Article • Medical Hypotheses, January 2007, Elsevier

    Prof Dr Faruk Nuri Aykan

  25. Penile metastasis of cutaneous malignant melanoma: a true hematogenous spread?

    Article • Melanoma Research, June 2006, Wolters Kluwer Health

    Dr Faruk TAS, Prof Dr Faruk Nuri Aykan

  26. Prognostic Factors in Pancreatic Carcinoma

    Article • American Journal of Clinical Oncology, December 2001, Wolters Kluwer Health

    Dr Faruk TAS, Prof Dr Faruk Nuri Aykan

  27. Measurement of Serum CA 19-9 May Be More Valuable Than CEA in Prediction of Recurrence in Patients With Gastric Cancer

    Article • American Journal of Clinical Oncology, April 2001, Wolters Kluwer Health

    Dr Faruk TAS, Prof Dr Faruk Nuri Aykan